MiCAN Technologies to Exhibit at GMP Pharma Congress & GMP Pharma Technica Expo 2026
MiCAN Technologies is pleased to announce its participation in GMP Pharma Congress & GMP Pharma Technica Expo 2026, one of Europe’s largest gatherings of pharmaceutical technology and quality control professionals.
MiCAN has been developing “MylcMAT,” a novel pyrogen test built upon “Mylc”—a proprietary immortalized blood cell line established through the company’s unique cell engineering technology.
As interest in alternative testing methods and innovative evaluation approaches continues to grow across Europe, MiCAN’s technology and initiatives are attracting increasing attention from pharmaceutical companies throughout the EU, as well as quality assurance and regulatory professionals.
At Booth A38, visitors can learn about “Mylc” and the MylcMAT pyrogen test, including key technical features, potential applications, and practical considerations for adoption.
MiCAN Technologies EUROPA GmbH (established in 2025) and MiCAN Technologies CEO Kazuo Miyazaki will attend in person. He is also scheduled to speak during the event.
We look forward to welcoming you at Booth A38.
Priod：24th – 25th March 2026
Venue：Rhein Main Congress Center Wiesbaden
Venue：Wiesbaden, Germany
